Frequency of skin cancer among psoriasis, vitiligo, and mycosis fungoides patients treated with narrowband ultraviolet B phototherapy
Photodermatology, Photoimmunology & Photomedicine · 2024
DOI: 10.1111/phpp.12936 ↗Kurz gefasst
Fachartikel in der Zeitschrift Photodermatology, Photoimmunology & Photomedicine, 2024. Verfasst von Ilit Mimouni und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Vitiligo, Ultraviolet Therapy, Psoriasis, Skin Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Narrowband ultraviolet B (NB‐UVB) phototherapy is a popular and relatively contemporary treatment option. However, only a few studies to date have explored the potential risk of skin cancer following NB‐UVB treatment.
Objective
This study aimed to investigate the potential long‐term risk of skin cancer in patients treated with NB‐UVB.
Methods
This cohort study included patients with psoriasis, vitiligo, and mycosis fungoides treated with NB‐UVB at two university hospitals in Israel in 2000–2005. Patients were followed up for skin cancer for at least 10 years. Data were extracted from the hospital and community medical records.
Results
A total of 767 patients were included in this study: 509 with psoriasis, 122 with vitiligo, and 136 with mycosis fungoides. The mean follow‐up duration was 13 years. Among these patients, 4.43% developed skin cancer during the follow‐up (3.93% had psoriasis, 2.46% had vitiligo, and 8.09% had mycosis fungoides). Old age and fair skin type were the only significant independent risk factors for skin cancer. There was no significant difference in the mean number of NB‐UVB treatments among patients who developed skin cancer and those who did not (99.09 vs. 94.79, respectively).
Conclusion
No association was observed between the number of NB‐UVB treatments and carcinogenesis in any study group. Age is a significant risk factor, and older patients treated with NB‐UVB should be followed up carefully.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Clalit Health Services, Tel Aviv, Israel.
- Maccabi Health Services, Tel Aviv, Israel.
- Department of Dermatology, Rabin Medical Center, Petah Tikva, Israel.
- Sheba Medical Center, Psoriasis and Phototherapy Center, Tel Hashomer, Israel.
ORCID-Profile: Felix Pavlotsky
Zitieren
APA
Mimouni, I., Shulman, J., Unes, A. A., Pavlovsky, L., & Pavlotsky, F. (2024). Frequency of skin cancer among psoriasis, vitiligo, and mycosis fungoides patients treated with narrowband ultraviolet B phototherapy. Photodermatology, Photoimmunology & Photomedicine. https://doi.org/10.1111/phpp.12936
Vancouver
Mimouni I, Shulman J, Unes AA, Pavlovsky L, Pavlotsky F. Frequency of skin cancer among psoriasis, vitiligo, and mycosis fungoides patients treated with narrowband ultraviolet B phototherapy. Photodermatology, Photoimmunology & Photomedicine. 2024. doi:10.1111/phpp.12936
BibTeX
@article{Mimouni2024,
author = {Mimouni, Ilit and Shulman, Julia and Unes, Awni Abu and Pavlovsky, Lev and Pavlotsky, Felix},
title = {Frequency of skin cancer among psoriasis, vitiligo, and mycosis fungoides patients treated with narrowband ultraviolet B phototherapy},
journal = {Photodermatology, Photoimmunology & Photomedicine},
year = {2024},
doi = {10.1111/phpp.12936}
}
EUVIMED